Werkgroep Cardiologische centra Nederland

ARTS-HF (Completed)

A randomized, double-blind, double-dummy, multi-center study to assess safety and efficacy of BAY 94-8862 in chronic heart failure with left ventricular systolic dysfunction and type 2 diabetes mellitus and / or chronic kidneydisease versus eplerenone.
Medicine
BAY 94-8862
Population
Heart failure
Phase
IIb
Starting year
2012
More information
ClinicalTrials.gov

Director of Study

drs. P.R. Nierop (Cardioloog)
Rotterdam, Franciscus Gasthuis

Publications: ARTS-HF

  • Discussant: ARTS-HF - finerenone versus eplerenone in patients with worsening chronic heart failure and diabetes and/or chronic kidney diseaseESC 2015 - ARTS-HF - Heart failure
  • Results of ARTS-HF: finerenone versus eplerenone in patients with worsening chronic heart failure and diabetes and/or chronic kidney diseaseESC 2015 - ARTS-HF - Heart failure

Publications by WCN study

Publications WCN studies by WCN member